Anticoagulation and Management of Coagulopathy in Neurosurgery

LEARNING OBJECTIVES

Upon completion of this CME activity, participants should be able to:

  • Review the physiologic mechanisms of hemostatis and pathophysiology of thrombosis.
  • Review common anticoagulant and antiplatelet pharmacology with focus on mechaism and measurement of effects.
  • Discuss the reversal of pharmacologic coagulopathies and prohemostatic agents.
  • Discuss new antithrombotic and anticoagulant agents highlighting benefits, unknowns and risks.

PRICING

AANS Members: Free | Non-members: $59

FACULTY INFORMATION

Faiz Ahmad, MD
Kumar Vasudevan, MD
Adam Webb, MD

PLANNING COMMITTEE

R. Webster Crowley, MD, FAANS
Eric M. Deshaies, MD, FAANS
Samantha Luebbering

DISCLOSURE INFORMATION

The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may have a relevance to their presentation are listed below.

Name:                  Relationship           Organization

Faiz Ahmad, MD    Consultant Fees      DePuy Synthes, Medtronic, Stryker, MiRus

Those who have reported they do not have any relationships with commercial interests:

R. Webster Crowley, MD, FAANS
Eric M. Deshaies, MD, FAANS
Samantha Luebbering
Kumar Vasudevan, MD
Adam Webb, MD

DISCLAIMER

The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve

ACCREDITATION/DESIGNATION

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM.

Physicians should claim only credit commensurate with the extent of their participation in the activity.

Term of approval is for three years, beginning from 11/15/2017 to 11/15/2020.

Upon successful completion of the CME test, credit will automatically be reflected in your member record. NonMembers must print a certificate and retain a copy for your CME records. 

Media utilized may include Adobe Flash.

Copyright © 2017 American Association of Neurological Surgeons

Key:

Complete
Failed
Available
Locked
Anticoagulation and Management of Coagulopathy in Neurosurgery
Open to view video.
Open to view video.
Quiz
10 Questions
10 Questions
Evaluation
6 Questions
6 Questions Course Evaluation
Certificate
1.25 AMA PRA Category 1 CreditTM credits  |  Certificate available
1.25 AMA PRA Category 1 CreditTM credits  |  Certificate available